Sangamo Therapeutics, Inc. ( SGMO) - Key Metrics
SGMO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | $0 | -$0.11 | -$0.09 | -$0.09 |
| 2025Q2 | $0.07 | -$0.08 | -$0.07 | -$0.07 |
| 2025Q1 | $0.03 | -$0.14 | -$0.12 | -$0.12 |
SGMO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | -1.47 |
| 2025Q2 | ? | -1.74 |
| 2025Q1 | ? | -1.18 |
SGMO
Price: $0.22
52 week price:
Earnings Per Share: -0.40 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 882100
Ebitda: -12.6 millionMarket Capitalization: 91.1 million